Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5358
Peer-review started: January 20, 2021
First decision: May 3, 2021
Revised: May 4, 2021
Accepted: June 4, 2021
Article in press: June 4, 2021
Published online: July 16, 2021
Processing time: 167 Days and 18.2 Hours
At the end of 2019, a new disease with pandemic potential appeared in China. It was a novel coronavirus called coronavirus disease 2019 (COVID-19). Later, in the first quarter of 2020, the World Health Organization declared the outbreak of this disease a pandemic. Elderly people, people with comorbidities, and health care professionals are more vulnerable to COVID-19. Obesity has been growing exponentially worldwide, affecting several age groups. It is a morbidity that is associated with genetic, epigenetic, environment factors and/or interaction between them. Obesity is associated with the development of several diseases including diabetes mellitus, mainly type 2. Diabetes affects a significant portion of the global population. Obesity and diabetes are among the main risk factors for the development of severe symptoms of COVID-19, and individuals with these conditions constitute a risk group. Based on a literature review on obesity in people with diabetes in the framework of the COVID-19 pandemic, this study presents updated important considerations and care to be taken with this population.
Core Tip: This article addresses obesity in people with diabetes in coronavirus disease 2019 (COVID-19) times, addressing the main points of the diseases and the interaction between them. Based on a literature review on obesity in people with diabetes in the framework of the COVID-19 pandemic, this study presents updated important considerations and care to be taken with this population.